Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs ServiceNow Inc (NOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs ServiceNow Inc — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while ServiceNow Inc trades at $140.86 (market cap $144.48B). The key difference: ServiceNow Inc is far larger — about 11.5× Halozyme Therapeutics Inc. Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, ServiceNow Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and ServiceNow Inc for 54 Days on average.
| HALO | NOW | |
|---|---|---|
Market Cap | $12.58B | $144.48B |
Volume | 2,179,278 | 11,801,699 |
Sector | Health | Technology |
52-Week High | $115.22 | $189.26 |
52-Week Low | $61.63 | $83.00 |
Typical Hold Time | 1 Days | 54 Days |
Enterprise Value | $14.49B | $148.27B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ServiceNow (NOW) trades at $139.75, up 1.36% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with $13.28B revenue in 2025, 74.77% gross margins, and consistent earnings beats. Recent AI product growth exceeding $1B annual contract value and positive market sentiment position the stock for potential upside toward the $146.04 consensus target.
Outlook remains positive with AI-driven growth catalysts, though premium valuation (P/E 87.34) and competitive pressures present risks. Wall Street maintains strong buy sentiment (87% buy ratings) with institutional confidence in the company's enterprise software leadership and AI integration strategy supporting long-term growth potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About ServiceNow Inc
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management (ITSM), expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service (PaaS).
Read more on NOW →
